Literature DB >> 8403504

Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

M Endoh1, M Yamashina, H Ohi, K Funahashi, T Ikuno, T Yasugi, J P Atkinson, H Okada.   

Abstract

The immunohistochemically stained membrane cofactor protein of complement (MCP/CD46), one of the complement regulatory proteins, was up-regulated in some diseased kidney tissues. MCP in diseased kidneys was strongly concentrated along the glomerular capillary walls as well as in the mesangial regions, while MCP in normal kidneys was weakly detected in all glomerular structural cells and in the epithelial cells of tubules. Since the enhanced staining was noted in those areas where depositions of C3b/C3c occurred, ongoing complement reaction might be responsible for the up-regulation of MCP expression. MCP expression may be up-regulated by complement fragments generated during complement activation in glomerulonephritis. Furthermore, anti-MCP staining was stronger in intensity in patients with moderate to massive proteinuria, indicating that up-regulation of MCP expression could be directly correlated to the kidney damage.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8403504      PMCID： PMC1534360          DOI： 10.1111/j.1365-2249.1993.tb05998.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  19 in total

1.  Characterization of three monoclonal antibodies against C3 with selective specificities.

Authors:  K Iida; K Mitomo; T Fujita; N Tamura
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

2.  The avidin-biotin complex in affinity cytochemistry.

Authors:  E A Bayer; E Skutelsky; M Wilchek
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Species-specific inhibition by glycophorins of complement activation via the alternative pathway.

Authors:  H Okada; H Tanaka
Journal:  Mol Immunol       Date:  1983-11       Impact factor: 4.407

4.  Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

Authors:  A Nicholson-Weller; J Burge; D T Fearon; P F Weller; K F Austen
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.

Authors:  M D Kazatchkine; D T Fearon; M D Appay; C Mandet; J Bariety
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Glomerular complement components in human glomerulonephritis.

Authors:  P J Verroust; C B Wilson; N R Cooper; T S Edgington; F J Dixon
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

7.  Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.

Authors:  J L Cole; G A Housley; T R Dykman; R P MacDermott; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.

Authors:  H Okada; H Tanaka; N Okada
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

9.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307
View more
  10 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

Review 3.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

4.  Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  L Cheng; S-J Gou; H-Y Qiu; L Ma; P Fu
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

5.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Authors:  Anna Richards; Elizabeth J Kemp; M Kathryn Liszewski; Judith A Goodship; Anne K Lampe; Ronny Decorte; M Hamza Müslümanoğlu; Salih Kavukcu; Guido Filler; Yves Pirson; Leana S Wen; John P Atkinson; Timothy H J Goodship
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

Review 6.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

7.  Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.

Authors:  Jeffrey M Saland; Benjamin L Shneider; Jonathan S Bromberg; Patricia A Shi; Stephen C Ward; Margret S Magid; Corinne Benchimol; Mouin G Seikaly; Sukru H Emre; Elena Bresin; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

8.  Activation of intrarenal complement system in mouse model for chronic cyclosporine nephrotoxicity.

Authors:  Young Ok Kim; Sun Woo Lim; Can Li; Hee Jung Kang; Kyung Ohk Ahn; Hyun Joo Yang; Jung Yeon Ghee; Su Hyun Kim; Jin Young Kim; Bum Soon Choi; Jin Kim; Chul Woo Yang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

9.  CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation.

Authors:  Matthias Wieser; Teresa Francisci; Daniel Lackner; Tilmann Buerckstuemmer; Kamilla Wasner; Wolf Eilenberg; Anton Stift; Markus Wahrmann; Georg A Böhmig; Johannes Grillari; Regina Grillari-Voglauer
Journal:  PLoS One       Date:  2019-04-08       Impact factor: 3.240

Review 10.  Overview of complement activation and regulation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.